Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Jun Arai

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Ecancermedicalscience|June 10, 2017
Bringing a humanistic approach to cancer clinical trialsRoberto Jun Arai, Elaine Santana Longo, Maria Helena Sponton, et al.
Antioxidants & Redox Signaling|September 20, 2021
Thiol-Based Antioxidants and the Epithelial/Mesenchymal Transition in CancerFernando Toshio Ogata, Alex Yuri Simões Sato, Lucia Coppo, et al.
Plos One|December 31, 2013
Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localizationFernando Toshio Ogata, Wagner Luiz Batista, Adriano Sartori, et al.
Clinics (Sao Paulo, Brazil)|October 13, 2021
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapyLaura Testa, Max Mano, Roberto Jun Arai, et al.
The Oncologist|March 27, 2019
Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and OpportunitiesRoberto Jun Arai, Rodrigo Santa Cruz Guindalini, Andrea Sabina Llera, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Ecancermedicalscience|June 10, 2017
Bringing a humanistic approach to cancer clinical trialsRoberto Jun Arai, Elaine Santana Longo, Maria Helena Sponton, et al.
Antioxidants & Redox Signaling|September 20, 2021
Thiol-Based Antioxidants and the Epithelial/Mesenchymal Transition in CancerFernando Toshio Ogata, Alex Yuri Simões Sato, Lucia Coppo, et al.
Plos One|December 31, 2013
Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localizationFernando Toshio Ogata, Wagner Luiz Batista, Adriano Sartori, et al.
Clinics (Sao Paulo, Brazil)|October 13, 2021
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapyLaura Testa, Max Mano, Roberto Jun Arai, et al.
The Oncologist|March 27, 2019
Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and OpportunitiesRoberto Jun Arai, Rodrigo Santa Cruz Guindalini, Andrea Sabina Llera, et al.
Pageof 1